[250 Pages Report] Expanding at a high CAGR of 8.4%, the global automated cell culture systems market is projected to increase from a valuation of USD 10.91 Billion in 2022 to USD 20.87 Billion by 2030.
Automated cell culture systems currently account for 44.5% share in the global cell culture market. Expansion of the automated cell culture systems market is being fuelled by rising stem cell research and development, drug breakthroughs, and increased investments towards the development of innovative products.
| Attribute | Details |
|---|---|
| Automated Cell Culture Systems Market Size (2022) | USD 10.91 Billion |
| Revenue Forecast (2030) | USD 20.87 Billion |
| Global Market Growth Rate (2022 to 2030) | 8.4% CAGR |
| Europe Marker Share | 35.7% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Particulars | Details |
|---|---|
| H1, 2021 | 8.23% |
| H1, 2022 Projected | 8.44% |
| H1, 2022 Outlook | 8.24% |
| BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 20 ↓ |
| BPS Change - H1, 2022 (O) - H1, 2021 | (+) 01 ↑ |
H1-2022 outlook period in comparison to H1-2022 projected period showed a negative growth in terms of Basis Point Share by 20 BPS. However, In H1-2022, the market growth rate of automated cell culture systems is expected to incline by 01 basis point share (BPS), as per FMI analysis.
The market for automated cell culture systems observes a decline in the BPS values due to the initial costs of automation and operational management. Moreover, equipment maintenance adds to additional cost overheads, thus proposing a hindrance to the overall market growth.
Although there are additional costs to automated cell culture systems, the future outlook is expected to be positive in terms of sales within the market. This is because automated systems can assist with bulk manufacturing of cell culture with management of cross contamination, within a closed system.
The key developments in the market include the advancement of the bioprocessing industry around the globe, especially within the South Asian region.
In laboratories, automated cell culture instruments are used because they mechanically accomplish the duties needed in creating and sustaining a cell culture. These instruments are frequently employed in cytology laboratories.
Automated cell culture equipment can execute operations such as diluting samples, cultivating cultures in liquid with constant spinning, plating cultures, and placing cultures in wells. The capacity of automated cell culture systems to develop optimal cell lines across the entire range of seeding, feeding, massaging, and cell multiplication has gained in popularity.
They help achieve strict standards demands while also decreasing contamination and human mistake. In the life sciences business, automated systems are employed for a variety of cell-based screening applications for both scientific and business purposes. The automated cell culture devices market expanded at a CAGR of 6.6% from 2015 to 2021.
Demand for automated cell culture equipment is increasing as the use of high-throughput cell lines in drug discovery research grows. The automated cell culture system demand is expected to progress at a CAGR of 8.4% from 2022 to 2030, with the global market predicted to reach a valuation of USD 20.87 Bn by 2030.
Automated cell culture facilitates the production of large numbers of high-quality cell lines for pharmacological studies, resulting in improved product safety and efficacy. Other common scientific applications include RNA interference (RNAi), cell-based drug transport, metabolism, and toxicology studies.
Principal Consultant
“Development of Novel 3D Cell Culture Techniques & Growing Need of Cell Culture Technology”
Development of novel three-dimensional cell culture techniques, as well as the increased demand for these techniques in biopharmaceutical research and vaccine production, is driving the market for automated cell culture systems.
The benefits of cell-based vaccinations are becoming more widely recognized. Researchers and manufacturers have been pushed to develop automated cell culture-based immunizations by increased global demand for novel vaccines to restrict and cure the coronavirus's transmission, as well as strict safety standards.
“Advancement in Technologies Driving Consumption of Automated Cell Culture Systems”
High-throughput screening technology has shown to be indispensable, particularly when a huge number of biological/chemical substances are being examined to treat a specific condition.
As a result, the automated cell culture systems market is expected to be driven by the use of automation and robots for speedy assessment of biochemical or biological activities.
“High Investments in R&D of Oncology Driving Europe Automated Cell Culture Systems Market Growth”
The global automated cell culture equipment market has been studied across North America, Latin America, Europe, East Asia, South Asia & Pacific, and the Middle East & Africa (MEA).
North America and Europe regional markets account for more than half of the global market share for automated cell culture systems. This could be related to a rise in the use of automated cell culture vessels as a result of an increase in oncology research and drug development.
The presence of excellent laboratory facilities is also likely to help these two regions to stand out. In 2022, North America is expected to account for 25.1% and Europe is likely to hold 35.7% of the global market share.
Given the growing demand for cell-based medicine delivery, East Asia will be the most attractive market for automated cell culture products. East Asia currently is likely to account for 20.9% of the global market share.
In 2022, South Asia & Oceania together may account for 14.2% of the global market share. This is due to the technological innovations such as next-generation sequencing, increased awareness, increased healthcare expenditure in national budgets, early availability of modern technologies, and fast-developing of research activities across the region.
The Latin America & MEA automated cell culture systems markets are expected to progress at a slightly slower rate than other regions but are expected to pick up pace towards the end of the projection period. At present, Latin America & MEA are predicted to account for 2.4% & 1.5% of the global market share, respectively.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
“Rising Cases of Cancer Driving Sales of Automated Cell Culture Systems”
Because of government assistance and strategic initiatives, the China automated cell culture systems market is expected to grow rapidly. To cater for the enormous patient population, China is putting a larger emphasis on technological advancements.
A high need for innovative therapies and solutions has arisen due to an increase in the number of elderly people as well as a high cancer incidence. Progress in the field of regenerative medicine, as well as well-developed sophisticated healthcare systems, are driving automated cell culture systems market expansion in China.
“High Spending on Healthcare Facilities Augmenting Sales Growth of Automated Cell Culture Systems”
The United States currently dominates the North America automated cell culture systems market, and this trend is likely to continue over the projection period. Growing demand for customized medications, as well as the existence of prominent companies in the market, is largely responsible for the market expansion.
Additionally, because healthcare is one of the country's top objectives, the US government is supportive of medical research. Increasing investments in the biomedical engineering industry are also boosting the country's market growth.
“Improved Technologies & Increasing Funding in R&D Boost Sales of Biotech Companies”
Over the projected period, biotech companies are expected to progress at a fast pace. The presence of a significant number of biotechnology companies, an increase in R&D investment in these firms, and a greater demand for alternative testing methods over animal techniques are all primary market drivers.
3D cell culture has advantages over 2D cell culture in terms of suitable oxygen and nutritional gradients, non-uniform cell-to-cell contacts, and realistic cell-to-cell interactions. Because of these factors, 3D cell culture is more suitable for drug discovery and advancement, leading in rising demand for automated cell culture systems.
Manufacturers of automated cell culture systems have been heavily investing in research to develop long-term solutions for both, biopharmaceutical and packaging industries. Sustainable vessel solutions are primarily made up of recyclable plastics and glass bottles.
Recycling, on the other hand, is not without its difficulties. Recycling a multi-layer flexible vessel with barrier material and base material plastic is a time-consuming task.
As a result, companies are actively investing in research aimed at making the recycling process easier. Automated cell culture systems market players are also concentrating on innovations and collaborations to enhance their market presence.
Some of the market players included in this report are Thermo Fisher Scientific, Corning Incorporated, Merck KGaA, Lonza Group Ltd, Sartorius AG, Tecan Trading AG, Hamilton Medical AG, Biospherix, and Promocell GmbH.
| Attribute | Details |
|---|---|
| Forecast Period | 2022 to 2030 |
| Historical Data Available for | 2015 to 2021 |
| Market Analysis | USD Billion for Value |
| Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia & Pacific; Middle East & Africa (MEA) |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Germany, UK, France, Spain, Italy, China, Japan, South Korea, India, Indonesia, Malaysia, Singapore, Australia, New Zealand, Turkey, South Africa, and GCC Countries |
| Key Market Segments Covered | Product, Cell Culture, Application, End User, Region |
| Key Companies Profiled |
Thermo Fisher Scientific; Corning Incorporated; Merck KGaA; Lonza Group Ltd; Sartorius AG; Tecan Trading AG; Hamilton Medical AG; Biospherix; Promocell GmbH |
| Pricing | Available upon Request |
The global automated cell culture systems market is predicted to progress at a high CAGR of 8.4% from 2022 to 2030.
The global market for automated cell culture systems is currently worth USD 10.91 Bn.
Key suppliers of automated cell culture systems are Thermo Fisher Scientific, Corning Incorporated, Merck KGaA, Lonza Group Ltd, Sartorius AG, Tecan Trading AG, Hamilton Medical AG, Biospherix, and Promocell GmbH.
By the end of 2030, automated cell culture system demand is anticipated to attain a market valuation of USD 20.87 Bn.
The Europe automated cell culture systems market currently holds 35.7% share in the global market.
1. Executive Summary 2. Market Overview 3. Key Market Trends 4. Market Background 5. Market Context 6. Global Automated Cell Culture Systems Market Value (USD Mn) Analysis 2015-2021 and Forecast, 2022-2030 7. Global Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030, By Product Type 7.1. Automated Cell Culture Storage Equipment 7.2. Automated Cell Culture Vessels 7.3. Bioreactors 7.4. Consumables 8. Global Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030, By Cell Culture Type 8.1. Finite Cell Line Cultures 8.2. Infinite Cell Line Cultures 9. Global Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030, By Application 9.1. Drug Development 9.2. Stem Cell Research 9.3. Regenerative Medicine 9.4. Cancer Research 10. Global Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030, by End User 10.1. Biotech Companies 10.2. Research Organizations 10.3. Academic Institutes 11. Global Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030, by Region 11.1. North America 11.2. Latin America 11.3. Europe 11.4. East Asia 11.5. South Asia 11.6. Oceania 11.7. Middle East and Africa 12. North America Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030 13. Latin America Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030 14. Europe Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030 15. South Asia Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030 16. East Asia Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030 17. Oceania Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030 18. Middle East and Africa Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030 19. Emerging & Key Countries Automated Cell Culture Systems Market Analysis 2015-2021 and Forecast 2022-2030 20. Market Structure Analysis 21. Competition Analysis 21.1. Thermo Fisher Scientific 21.2. Corning Incorporated 21.3. Merck KGaA 21.4. Lonza Group Ltd 21.5. Sartorius AG 21.6. Tecan Trading AG 21.7. Hamilton Medical AG 21.8. Biospherix 21.9. Promocell GmbH 22. Assumptions and Acronyms Used 23. Research Methodology
Explore Healthcare Insights
View Reports
Automated Cell Culture Systems Market
